Cargando…

Active syndromic surveillance of COVID-19 in Israel

Syndromic surveillance systems monitor disease indicators to detect emergence of diseases and track their progression. Here, we report on a rapidly deployed active syndromic surveillance system for tracking COVID-19 in Israel. The system was a novel combination of active and passive components: Ads...

Descripción completa

Detalles Bibliográficos
Autor principal: Yom-Tov, Elad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712517/
https://www.ncbi.nlm.nih.gov/pubmed/34961786
http://dx.doi.org/10.1038/s41598-021-03977-3
_version_ 1784623571719421952
author Yom-Tov, Elad
author_facet Yom-Tov, Elad
author_sort Yom-Tov, Elad
collection PubMed
description Syndromic surveillance systems monitor disease indicators to detect emergence of diseases and track their progression. Here, we report on a rapidly deployed active syndromic surveillance system for tracking COVID-19 in Israel. The system was a novel combination of active and passive components: Ads were shown to people searching for COVID-19 symptoms on the Google search engine. Those who clicked on the ads were referred to a chat bot which helped them decide whether they needed urgent medical care. Through its conversion optimization mechanism, the ad system was guided to focus on those people who required such care. Over 6 months, the ads were shown approximately 214,000 times and clicked on 12,000 times, and 722 people were informed they needed urgent care. Click rates on ads and the fraction of people deemed to require urgent care were correlated with the hospitalization rate ([Formula: see text] and [Formula: see text] , respectively) with a lead time of 9 days. Males and younger people were more likely to use the system, and younger people were more likely to be determined to require urgent care (slope: [Formula: see text], [Formula: see text] ). Thus, the system can assist in predicting case numbers and hospital load at a significant lead time and, simultaneously, help people determine if they need medical care.
format Online
Article
Text
id pubmed-8712517
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-87125172021-12-28 Active syndromic surveillance of COVID-19 in Israel Yom-Tov, Elad Sci Rep Article Syndromic surveillance systems monitor disease indicators to detect emergence of diseases and track their progression. Here, we report on a rapidly deployed active syndromic surveillance system for tracking COVID-19 in Israel. The system was a novel combination of active and passive components: Ads were shown to people searching for COVID-19 symptoms on the Google search engine. Those who clicked on the ads were referred to a chat bot which helped them decide whether they needed urgent medical care. Through its conversion optimization mechanism, the ad system was guided to focus on those people who required such care. Over 6 months, the ads were shown approximately 214,000 times and clicked on 12,000 times, and 722 people were informed they needed urgent care. Click rates on ads and the fraction of people deemed to require urgent care were correlated with the hospitalization rate ([Formula: see text] and [Formula: see text] , respectively) with a lead time of 9 days. Males and younger people were more likely to use the system, and younger people were more likely to be determined to require urgent care (slope: [Formula: see text], [Formula: see text] ). Thus, the system can assist in predicting case numbers and hospital load at a significant lead time and, simultaneously, help people determine if they need medical care. Nature Publishing Group UK 2021-12-27 /pmc/articles/PMC8712517/ /pubmed/34961786 http://dx.doi.org/10.1038/s41598-021-03977-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Yom-Tov, Elad
Active syndromic surveillance of COVID-19 in Israel
title Active syndromic surveillance of COVID-19 in Israel
title_full Active syndromic surveillance of COVID-19 in Israel
title_fullStr Active syndromic surveillance of COVID-19 in Israel
title_full_unstemmed Active syndromic surveillance of COVID-19 in Israel
title_short Active syndromic surveillance of COVID-19 in Israel
title_sort active syndromic surveillance of covid-19 in israel
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712517/
https://www.ncbi.nlm.nih.gov/pubmed/34961786
http://dx.doi.org/10.1038/s41598-021-03977-3
work_keys_str_mv AT yomtovelad activesyndromicsurveillanceofcovid19inisrael